Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$2.28 - $3.03 $4,156 - $5,523
1,823 New
1,823 $5,000
Q1 2023

Apr 27, 2023

BUY
$1.89 - $2.93 $9,353 - $14,500
4,949 Added 208.03%
7,328 $15,000
Q4 2022

Feb 02, 2023

BUY
$2.48 - $3.43 $5,225 - $7,227
2,107 Added 774.63%
2,379 $6,000
Q3 2022

Nov 04, 2022

BUY
$3.14 - $6.43 $854 - $1,748
272 New
272 $0
Q2 2022

Aug 03, 2022

SELL
$4.74 - $8.15 $51,490 - $88,533
-10,863 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$6.47 - $9.57 $66,388 - $98,197
10,261 Added 1704.49%
10,863 $82,000
Q4 2021

Feb 23, 2022

BUY
$9.02 - $13.5 $5,430 - $8,127
602 New
602 $5,000
Q2 2021

Aug 12, 2021

SELL
$14.92 - $23.23 $25,557 - $39,792
-1,713 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$7.33 - $21.06 $12,556 - $36,075
1,713 New
1,713 $31,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $505M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.